Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JINNY E CHANG

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1336266857
CMS profile
151080
Location
SANTA BARBARA, CA

General Payments · PY2018–2024

$12,523.73

  • Reported across 623 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$861.60

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $861.60 35

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,683.94 93
PY2019 $2,566.57 157
PY2020 $1,628.69 88
PY2021 $2,117.92 100
PY2022 $2,302.62 97
PY2023 $1,362.39 53
PY2024 $861.60 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $25.50 04/16/2024 Food and Beverage Undisputed 01/23/2026 1105858202 CMS
AstraZeneca Pharmaceuticals LP $24.35 09/05/2024 Food and Beverage Undisputed 01/23/2026 1104209059 CMS
AstraZeneca Pharmaceuticals LP $26.13 10/23/2024 Food and Beverage Undisputed 01/23/2026 1105401055 CMS
AstraZeneca Pharmaceuticals LP $21.28 12/18/2024 Food and Beverage Undisputed 01/23/2026 1105489505 CMS
BioCryst US Sales Co., LLC $25.79 03/13/2024 Food and Beverage Undisputed 01/23/2026 1117474114 CMS
BioCryst US Sales Co., LLC $20.88 09/24/2024 Food and Beverage Undisputed 01/23/2026 1117473730 CMS
BioCryst US Sales Co., LLC $13.84 12/03/2024 Food and Beverage Undisputed 01/23/2026 1117482356 CMS
CSL Behring $27.49 04/10/2024 Food and Beverage Undisputed 01/23/2026 1134606391 CMS
CSL Behring $29.53 11/06/2024 Food and Beverage Undisputed 01/23/2026 1134606431 CMS
CSL Behring $32.62 11/06/2024 Food and Beverage Undisputed 01/23/2026 1134606433 CMS
GENZYME CORPORATION $21.13 08/21/2024 Food and Beverage Undisputed 01/23/2026 1139786889 CMS
GENZYME CORPORATION $20.82 09/24/2024 Food and Beverage Undisputed 01/23/2026 1139786897 CMS
GlaxoSmithKline, LLC. $16.43 03/14/2024 Food and Beverage Undisputed 01/23/2026 1116294839 CMS
GlaxoSmithKline, LLC. $20.19 03/19/2024 Food and Beverage Undisputed 01/23/2026 1116455979 CMS
GlaxoSmithKline, LLC. $14.60 04/15/2024 Food and Beverage Undisputed 01/23/2026 1116596817 CMS
GlaxoSmithKline, LLC. $27.73 06/04/2024 Food and Beverage Undisputed 01/23/2026 1116693629 CMS
GlaxoSmithKline, LLC. $17.81 07/11/2024 Food and Beverage Undisputed 01/23/2026 1116704366 CMS
Greer Laboratories, Inc. $32.24 05/07/2024 Food and Beverage Undisputed 01/23/2026 1131113377 CMS
Hikma Pharmaceuticals USA $22.36 11/07/2024 Food and Beverage Undisputed 01/23/2026 1127504482 CMS
Novartis Pharmaceuticals Corporation $34.19 02/28/2024 Food and Beverage Undisputed 01/23/2026 1086723737 CMS
Novartis Pharmaceuticals Corporation $16.77 07/03/2024 Food and Beverage Undisputed 01/23/2026 1086723769 CMS
Novartis Pharmaceuticals Corporation $27.10 10/23/2024 Food and Beverage Undisputed 01/23/2026 1086723791 CMS
PFIZER INC. $41.38 05/19/2024 Food and Beverage Undisputed 01/23/2026 1131412444 CMS
Pharming Healthcare, Inc. $28.36 04/26/2024 Food and Beverage Undisputed 01/23/2026 1132144897 CMS
Pharming Healthcare, Inc. $22.22 08/19/2024 Food and Beverage Undisputed 01/23/2026 1132144903 CMS
Pharming Healthcare, Inc. $22.46 10/03/2024 Food and Beverage Undisputed 01/23/2026 1132144909 CMS
Regeneron Healthcare Solutions, Inc. $30.15 05/21/2024 Food and Beverage Undisputed 01/23/2026 1114021768 CMS
Regeneron Healthcare Solutions, Inc. $28.48 09/10/2024 Food and Beverage Undisputed 01/23/2026 1114021770 CMS
Regeneron Healthcare Solutions, Inc. $31.00 11/20/2024 Food and Beverage Undisputed 01/23/2026 1114021772 CMS
Takeda Pharmaceuticals U.S.A., Inc. $30.69 04/18/2024 Food and Beverage Undisputed 01/23/2026 1137507388 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.34 05/08/2024 Food and Beverage Undisputed 01/23/2026 1137507392 CMS
Takeda Pharmaceuticals U.S.A., Inc. $31.63 07/15/2024 Food and Beverage Undisputed 01/23/2026 1137507395 CMS
Takeda Pharmaceuticals U.S.A., Inc. $9.05 07/26/2024 Food and Beverage Undisputed 01/23/2026 1137507399 CMS
Takeda Pharmaceuticals U.S.A., Inc. $20.80 08/13/2024 Food and Beverage Undisputed 01/23/2026 1137507403 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.26 11/21/2024 Food and Beverage Undisputed 01/23/2026 1137507407 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.